Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Peter Libby MD
Peter Libby MD Advisory Board
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI Advisory Board
Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI
Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI Advisory Board
See All Experts
Published in Cardiology

Journal Scan / Research · January 22, 2015

Bivalirudin vs Heparin ± GPI Treatment in PCI Patients With STEMI

Journal of the American College of Cardiology

 

 Save  Recommend
 Share

Additional Info

Journal of the American College of Cardiology
Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: Pooled Patient-Level Analysis From the HORIZONS-AMI and EUROMAX Trials
J Am Coll Cardiol 2015 Jan 06;65(1)27-38, GW Stone, R Mehran, P Goldstein, B Witzenbichler, A van’t Hof, G Guagliumi, CW Hamm, P Généreux, P Clemmensen, SJ Pocock, BJ Gersh, D Bernstein, EN Deliargyris, PG Steg

Further Reading

Most Read This Week

Recently Updated